Green Thumb Industries Inc. GTBIF
We take great care to ensure that the data presented and summarized in this overview for Green Thumb Industries Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding GTBIF
View all-
Gofen & Glossberg LLC128KShares$983,2740.03% of portfolio
-
Albert D Mason Inc90.8KShares$699,3980.73% of portfolio
-
Thompson Investment Management, Inc.48.8KShares$375,6060.07% of portfolio
-
Rothschild Investment Corp43.5KShares$334,9500.04% of portfolio
-
Org Partners LLC Roanoke, IN1.19KShares$9,1240.0% of portfolio
-
Game Plan Financial Advisors, LLC300Shares$2,3100.0% of portfolio
-
Strategic Investment Solutions, Inc. /Il Orland Park, IL160Shares$1,2320.0% of portfolio
-
Horrell Capital Management, Inc.110Shares$8470.0% of portfolio
-
West Oak Capital, LLC101Shares$7770.0% of portfolio
Latest Institutional Activity in GTBIF
Top Purchases
Top Sells
About GTBIF
Green Thumb Industries Inc. engages in manufacture, distribution, and sale of various cannabis products for medical and adult-use in the United States. It offers cannabis flower; and processed and packaged products, including pre-rolls, concentrates, vapes, tinctures, edibles, topicals, and other cannabis-related products under the Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands. The company distributes its products primarily to third-party retail stores, as well as sells finished products directly to consumers in its own retail stores. As of April 11, 2022, it owned and operated 77 retail stores in the United States. The company was founded in 2014 and is headquartered in Chicago, Illinois.
Insider Transactions at GTBIF
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 01
2024
|
Dawn Wilson Barnes |
BUY
Grant, award, or other acquisition
|
Direct |
4,709
+11.42%
|
-
|
|
Dec 01
2024
|
Ethan Nadelmann |
BUY
Grant, award, or other acquisition
|
Direct |
4,709
+13.76%
|
-
|
|
Dec 01
2024
|
Hannah Scofield Buchan |
BUY
Grant, award, or other acquisition
|
Direct |
4,709
+12.28%
|
-
|
|
Dec 01
2024
|
Jeffrey H Goldman |
BUY
Grant, award, or other acquisition
|
Direct |
12,116
+0.44%
|
-
|
|
Dec 01
2024
|
Richard Reisin |
BUY
Grant, award, or other acquisition
|
Direct |
6,458
+19.45%
|
-
|
|
Nov 26
2024
|
Bret Kravitz GENERAL COUNSEL AND SECRETARY |
SELL
Open market or private sale
|
Direct |
2,488
-0.37%
|
$22,392
$9.01 P/Share
|
|
Nov 22
2024
|
Bret Kravitz GENERAL COUNSEL AND SECRETARY |
SELL
Open market or private sale
|
Direct |
3,450
-0.51%
|
$31,050
$9.16 P/Share
|
|
Nov 08
2024
|
Anthony Georgiadis PRESIDENT |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
80
+0.68%
|
$640
$8.65 P/Share
|
|
Nov 08
2024
|
Anthony Georgiadis PRESIDENT |
SELL
Open market or private sale
|
Indirect |
1,138
-8.67%
|
$10,242
$9.26 P/Share
|
|
Nov 08
2024
|
Benjamin Kovler CHAIRMAN & CEO |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
66
+50.0%
|
$528
$8.65 P/Share
|
|
Nov 08
2024
|
Benjamin Kovler CHAIRMAN & CEO |
SELL
Open market or private sale
|
Indirect |
938
-100.0%
|
$8,442
$9.26 P/Share
|
|
Nov 01
2024
|
Benjamin Kovler CHAIRMAN & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
750,000
+45.62%
|
-
|
|
Nov 01
2024
|
Mathew Faulkner CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
300,000
+41.01%
|
-
|
|
Nov 01
2024
|
Bret Kravitz GENERAL COUNSEL AND SECRETARY |
BUY
Grant, award, or other acquisition
|
Direct |
300,000
+30.66%
|
-
|
|
Nov 01
2024
|
Anthony Georgiadis PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct |
750,000
+44.84%
|
-
|
|
Sep 01
2024
|
Ethan Nadelmann |
BUY
Grant, award, or other acquisition
|
Direct |
4,557
+15.52%
|
-
|
|
Sep 01
2024
|
Richard Reisin |
BUY
Grant, award, or other acquisition
|
Direct |
6,250
+23.55%
|
-
|
|
Sep 01
2024
|
Dawn Wilson Barnes |
BUY
Grant, award, or other acquisition
|
Direct |
4,557
+12.53%
|
-
|
|
Sep 01
2024
|
Hannah Scofield Buchan |
BUY
Grant, award, or other acquisition
|
Direct |
4,557
+13.61%
|
-
|
|
Sep 01
2024
|
Jeffrey H Goldman |
BUY
Grant, award, or other acquisition
|
Direct |
5,859
+0.43%
|
-
|
Last 12 Months Summary
| Grant, award, or other acquisition | 2.25M shares |
|---|---|
| Exercise of conversion of derivative security | 628K shares |
| Exercise of in-the-money or at-the-money derivatives securities | 146 shares |
| Payment of exercise price or tax liability | 533K shares |
|---|---|
| Open market or private sale | 141K shares |